Inventor · disambiguated record
William James Jonathan Finlay
Also filed as: FINLAY JR WILLIAM · FINLAY WILLIAM · FINLAY WILLIAM JAMES JOHNATHAN · FINLAY WILLIAM JAMES JONATHAN
26 granted patents·19 pending applications·148 citations·filing 1988–2025
94Inventor score
Files withPFIZER7CENTESSA PHARMACEUTICALS UK LTD5GRANULAR THERAPEUTICS LTD3ULTRAHUMAN EIGHT LTD3ULTRAHUMAN FOUR LTD3
Top patents by PatentIndex Score
45 records- 0193US10858435B2PD1 binding agentsULTRAHUMAN NINE LTD·Filed 2020·Granted Dec 8, 2020·10 cites·20 claims
- 0293US9683998B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2014·Granted Jun 20, 2017·32 cites·13 claims
- 0392US10611838B2C-KIT antibodiesULTRAHUMAN FIVE LTD·Filed 2019·Granted Apr 7, 2020·10 cites·24 claims
- 0490US11474112B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2019·Granted Oct 18, 2022·4 cites·27 claims
- 0589US10683350B2Anti-CD47 antibody moleculesULTRAHUMAN FOUR LTD·Filed 2019·Granted Jun 16, 2020·3 cites·10 claims
- 0687US10858434B2PD1 binding agentsULTRAHUMAN EIGHT LTD·Filed 2020·Granted Dec 8, 2020·2 cites·20 claims
- 0784US11851460B2PD1 binding agentsULTRAHUMAN EIGHT LTD·Filed 2020·Granted Dec 26, 2023·1 cites·17 claims
- 0884US2025109202A1Anti-CD47 BINDING AGENTSCENTESSA PHARMACEUTICALS UK LTD·Filed 2024·Application pending·0 cites
- 0983US11370840B2Method of using anti-CD47 antibody moleculesULTRAHUMAN FOUR LTD·Filed 2020·Granted Jun 28, 2022·1 cites·20 claims
- 1083US2025066475A1C-kit antibodiesGRANULAR THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1182US10647756B2Humanized antibodiesPFIZER·Filed 2016·Granted May 12, 2020·2 cites·14 claims
- 1281US11377493B2Method for treating cancer with c-kit antibodiesGRANULAR THERAPEUTICS LTD·Filed 2020·Granted Jul 5, 2022·1 cites·21 claims
- 1379US12372536B2Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereofPFIZER·Filed 2022·Granted Jul 29, 2025·0 cites·30 claims
- 1479US2024124590A1Pd1 binding agentsULTRAHUMAN ELGHT LTD·Filed 2023·Application pending·0 cites
- 1578US12415861B2Anti C-MET antibodiesCENTESSA PHARMACEUTICALS UK LTD·Filed 2023·Granted Sep 16, 2025·0 cites·19 claims
- 1676US12173067B2C-KIT antibodies and method for treating cancer with suchGRANULAR THERAPEUTICS LTD·Filed 2022·Granted Dec 24, 2024·0 cites·21 claims
- 1775US2022332819A1Binding agentsULTRAHUMAN FOUR LTD·Filed 2022·Application pending·0 cites
- 1874US11673960B2Anti C-MET antibodiesLockBody Therapeutics Ltd·Filed 2019·Granted Jun 13, 2023·1 cites·28 claims
- 1973US2023322944A1Anti-cd122 antibodies and uses thereofVILLARIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2073US2023357420A1Anti-cd122 antibodies and uses thereofVILLARIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2172US4871354AWet-dry bag with lyphozation vialWEST CO·Filed 1988·Granted Oct 3, 1989·80 cites·8 claims
- 2269US2025109206A1Activatable bispecific anti-cd3 and anti-pd-l1 proteins and uses thereofCENTESSA PHARMACEUTICALS UK LTD·Filed 2024·Application pending·0 cites
- 2368US2025002585A1Activatable bispecific anti-cd47 and anti-pd-l1 proteins and uses thereofCENTESSA PHARMACEUTICALS UK LTD·Filed 2024·Application pending·0 cites
- 2465US12479920B2PD1 and VEGFR2 dual-binding agentsOTTIMO PHARMA LTD·Filed 2025·Granted Nov 25, 2025·0 cites·30 claims
- 2564US10472410B2Isolation of therapeutic target specific VNAR domains to ICOSLTHE UNIV COURT OF THE UNIV OF ABERDEEN·Filed 2014·Granted Nov 12, 2019·1 cites·6 claims
- 2663US8313942B2Compatible display vector systemsHUFTON SIMON EVAN·Filed 2009·Granted Nov 20, 2012·0 cites·14 claims
- 2762US11459377B2Synthetic library of specific binding moleculesELASMOGEN LTD·Filed 2019·Granted Oct 4, 2022·0 cites·19 claims
- 2861US9523092B2Compatible display vector systemsWYETH LLC·Filed 2012·Granted Dec 20, 2016·0 cites·10 claims
- 2960US11578428B2Humanized antibodiesPFIZER·Filed 2020·Granted Feb 14, 2023·0 cites·15 claims
- 3059US12421310B2CD47 binding agentsCENTESSA PHARMACEUTICALS UK LTD·Filed 2019·Granted Sep 23, 2025·0 cites·28 claims
- 3159US10975165B2De-immunised anti-ERBB3 antibodiesULTRAHUMAN THIRTEEN LTD·Filed 2020·Granted Apr 13, 2021·0 cites·19 claims
- 3258US2024101674A1Pd1 and vegfr2 dual-binding agentsULTRAHUMAN EIGHT LTD·Filed 2020·Application pending·0 cites
- 3356US2021189003A1De-immunised anti-erbb3 antibodiesULTRAHUMAN THIRTEEN LTD·Filed 2021·Application pending·0 cites
- 3456US2021101981A1Pd1 binding agentsULTRAHUMAN NINE LTD·Filed 2020·Application pending·0 cites
- 3555US2018052175A1Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereofPFIZER·Filed 2017·Application pending·0 cites
- 3655US2010113304A1Compatible display vector systemsWYETH CORP·Filed 2009·Application pending·0 cites
- 3753US10202438B2Synthetic library of specific binding moleculesTHE UNIV COURT OF THE UNIV OF ABERDEEN·Filed 2014·Granted Feb 12, 2019·0 cites·3 claims
- 3852US2010124764A1Single chain antibody library designWYETH CORP·Filed 2009·Application pending·0 cites
- 3950US10457736B2Binding agentsULTRAHUMAN ONE LTD·Filed 2018·Granted Oct 29, 2019·0 cites·20 claims
- 4049US2010143349A1Humanized anti-rage antibodyWYETH CORP·Filed 2009·Application pending·0 cites
- 4146US2010062038A1Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and OsteoclastsNAT UNIV IRELAND·Filed 2008·Application pending·0 cites
- 4246US2023192899A1Activatable bispecific antibodies comprising a linker between the two binding domains which is a human immunoglobulin hinge region, or a variant thereof, and uses thereofLockBody Therapeutics Ltd·Filed 2020·Application pending·0 cites
- 4346US2019375846A1Binding agentsULTRAHUMAN ONE LTD·Filed 2019·Application pending·0 cites
- 4440US11655300B2Colony stimulating factor 1 receptor (CSF1R) antibodies and immunoconjugates thereofULTRAHUMAN TWELVE LTD·Filed 2019·Granted May 23, 2023·0 cites·21 claims
- 4536US2016207991A1Therapeutic AntibodyPFIZER·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William James Jonathan Finlay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →